(Q48480707)
Statements
1 reference
Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX. (English)
1 reference
1 reference
Ernest Choy
1 reference
Frank McKenna
1 reference
Robert Valente
1 reference
Niti Goel
1 reference
Brenda Vanlunen
1 reference
Owen Davies
1 reference
Hans-Detlev Stahl
1 reference
Rieke Alten
1 reference
16 February 2012
1 reference
1 reference
51
1 reference
7
1 reference
1226-1234
1 reference
Identifiers
1 reference